10x Genomics (MEX:TXG) 5-Day RSI: N/A (As of Jul. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:TXG 10x Genomics Inc MEX:TXG
60 GF Score
Price MXN335.54
GF Value MXN145.06
! 8 Warning Signs
View Full Analysis

What is 10x Genomics 5-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2026-07-18), 10x Genomics's 5-Day RSI is N/A.

The industry rank for 10x Genomics's 5-Day RSI or its related term are showing as below:

MEX:TXG's 5-Day RSI is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 51.36
* Ranked among companies with meaningful 5-Day RSI only.

10x Genomics  (MEX:TXG) 5-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.


10x Genomics 5-Day RSI Related Terms


MEX:TXG vs DOCS, WAY, PRVA: 5-Day RSI Comparison

For the Health Information Services subindustry, 10x Genomics's 5-Day RSI, along with its competitors' market caps and 5-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


10x Genomics 5-Day RSI vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, 10x Genomics's 5-Day RSI distribution charts can be found below:

* The bar in red indicates where 10x Genomics's 5-Day RSI falls into.


MEX:TXG
60GF Score
10x Genomics Inc MEX:TXG
5-Day RSI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

10x Genomics  (MEX:TXG) 5-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is 10x Genomics (MEX:TXG) Overvalued in 2026?

Based on GuruFocus' analysis, 10x Genomics stock appears to be overvalued. The current stock price of MXN335.54 is trading 131.3% above its estimated GF Value™ of MXN145.06.

Key valuation signals for MEX:TXG:

  • 5-Day RSI: N/A
  • GF Value™: MXN145.06 vs. price of MXN335.54 (131.3% above fair value)
  • GF Score™: 60/100 with 8 warning signs

No single metric tells the full story. See the MEX:TXG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


10x Genomics Business Description

Other Exchanges TXG:USA0A88:UK1KJ:Germany
Address 6230 Stoneridge Mall Road, Pleasanton, CA, USA, 94588
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
60GF Score

Get the complete analysis for MEX:TXG

5-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN335.54
Price
MXN145.06
GF Value